 |
Sodium phenylbutyrate |
|---|---|
| Trade Name | Buphenyl |
| Orphan Indication | Spinal muscular atrophy |
| USA Market Approval | USA |
| USA Designation Date | 2007-01-25 00:00:00 |
| Sponsor | OrphaMed, Inc.;7720 N. Dobson Road, subsidiary of Medicis Pharmaceutical Corp.;Scottsdale, Arizona, 85256 |
Related Access Program
Pfizer – Non Small Cell Lung Cancer With ALK or ROS1 Rearrangement
Pfizer – Non Small Cell Lung Cancer Harboring Molecular Alterations
Biogen – Infantile-onset Spinal Muscular Atrophy
Novartis Pharmaceuticals – Non-small Cell Lung Cancer (NSCLC)
Biogen – Infantile-onset Spinal Muscular Atrophy (SMA)